We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$2.3B
AUM Growth
-$1.11B
Cap. Flow
-$1.5B
Cap. Flow %
-65.48%
Top 10 Hldgs %
53.43%
Holding
2,226
New
717
Increased
245
Reduced
521
Closed
719

Sector Composition

Rank Sector Weight
1 Technology 3.77%
2 Consumer Discretionary 2.1%
3 Financials 2.02%
4 Healthcare 2%
5 Communication Services 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPE
1451
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$14K ﹤0.01%
+84
New +$31.3K
ARTL icon
1452
Artelo Biosciences
ARTL
$2.68M
$13K ﹤0.01%
+91
New +$18K
PZG icon
1453
Paramount Gold Nevada
PZG
$96.1M
$13K ﹤0.01%
+18,369
New +$14.5K
SONN
1454
DELISTED
Sonnet BioTherapeutics
SONN
$13K ﹤0.01%
13
-2
-13% -$2.87K
URG
1455
Ur-Energy
URG
$485M
$13K ﹤0.01%
10,455
-21,628
-67% -$35.5K
XTNT icon
1456
Xtant Medical Holdings
XTNT
$60.3M
$13K ﹤0.01%
+22,958
New +$21.6K
PFIE
1457
DELISTED
Profire Energy, Inc
PFIE
$13K ﹤0.01%
12,447
-17,189
-58% -$19.5K
TMDI
1458
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$13K ﹤0.01%
+21,193
New +$23.9K
CALA
1459
DELISTED
Calithera Biosciences, Inc
CALA
$13K ﹤0.01%
+941
New +$23.6K
NBRV
1460
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$13K ﹤0.01%
881
-716
-45% -$17K
KAVL
1461
DELISTED
Kaival Brands Innovations Group
KAVL
$12K ﹤0.01%
+743
New +$20.8K
FEED
1462
ENvue Medical Inc
FEED
$1.92M
$12K ﹤0.01%
+5
New +$14.9K
BIOL
1463
DELISTED
Biolase, Inc.
BIOL
$12K ﹤0.01%
12
CCLP
1464
DELISTED
CSI Compressco LP
CCLP
$12K ﹤0.01%
+10,065
New +$14.4K
JT
1465
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$12K ﹤0.01%
+11,824
New +$15.4K
NVCN
1466
DELISTED
Neovasc Inc.
NVCN
$12K ﹤0.01%
+1,012
New +$17.3K
ELOX
1467
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$12K ﹤0.01%
+437
New +$19K
ALAR
1468
Alarum Technologies
ALAR
$12.3M
$11K ﹤0.01%
1,577
+340
+27% +$3.44K
DXF
1469
Eason Technology Ltd
DXF
$1.5M
$11K ﹤0.01%
+8
New +$12.7K
XPL icon
1470
Solitario Resources
XPL
$68.3M
$11K ﹤0.01%
+22,766
New +$11.7K
ASAP
1471
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$11K ﹤0.01%
+727
New +$16.9K
NH
1472
DELISTED
NantHealth, Inc
NH
$11K ﹤0.01%
+686
New +$14.5K
KIQ
1473
DELISTED
Kelso Technologies Inc.
KIQ
$11K ﹤0.01%
+24,798
New +$14.4K
ETHZW
1474
DELISTED
ETHZilla Corp Warrant
ETHZW
$10K ﹤0.01%
+14,975
New +$13.9K
DSS icon
1475
DSS Inc
DSS
$5.39M
$10K ﹤0.01%
802
-1,560
-66% -$28.8K

Similar funds

Two Sigma Securities's Q4 2021 Portfolio in Review

As of Q4 2021, Two Sigma Securities held 2,226 positions worth $2.3B, down 33% from $3.41B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Two Sigma Securities withdrew a net $1.5B in Q4 2021, closing 719 positions and reducing 521 holdings. Its most notable exit was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $8.07M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Two Sigma Securities opened a new position in iShares MSCI Emerging Markets ETF worth $9.7M.

  • Two Sigma Securities's largest Q4 2021 buy was iShares MSCI Emerging Markets ETF: 198,588 shares worth $9.7M.
  • Two Sigma Securities added most to Amazon in Q4 2021, an estimated $15.5M increase.
  • Two Sigma Securities's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.5M.
  • Two Sigma Securities fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2021, selling an estimated $8.07M.
  • Two Sigma Securities's ten largest holdings make up 53% of its $2.3B portfolio in Q4 2021.
  • Two Sigma Securities opened 717 new positions and closed 719 in Q4 2021.
  • Two Sigma Securities's portfolio value fell 33% quarter-over-quarter to $2.3B.

Based on Two Sigma Securities's 13F filing for Q4 2021, filed 14 Feb 2022.